Ads
related to: crispr therapeutics
Search results
Why Is CRISPR Therapeutics (CRSP) Up 12% Since Last Earnings Report?
Zacks via Yahoo Finance· 1 day agoA month has gone by since the last earnings report for CRISPR Therapeutics AG (CRSP). Shares have...
Corient Private Wealth LLC Sells 546 Shares of CRISPR Therapeutics AG (NASDAQ:CRSP)
ETF DAILY NEWS· 2 days agoCorient Private Wealth LLC lessened its stake in shares of CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 5.8% during the fourth quarter, according ...
Cathie Wood Invests In 2 Biotechnology Stocks – Are They Worth Buying?
Benzinga via Yahoo Finance· 1 day agoWith her ARK Innovation ETF (ARKK: NYSE Arca), Cathie Wood makes large wagers on biotech businesses...
Cathie Wood Is Buying the Dip on These 2 Biotech Stocks. Should You?
Motley Fool via Yahoo Finance· 4 days agoCathie Wood is buying the dip on two biotechs in particular, so for her, the answer to that question...
Here's How Cathie Wood (Almost) Completely Missed the Boat on Artificial Intelligence (AI) -- and...
The Motley Fool via AOL· 6 days ago...Tesla ARK Bitcoin ETF HoldCo Coinbase Global Tesla Twist Bioscience 2 Coinbase Global Tesla...
The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks
Investor's Business Daily· 1 day agoVertex is also working on a next-generation triple regimen that proved non-inferior to the existing...
Top Stock Reports for NVIDIA, Tesla & Linde
Zacks via Yahoo Finance· 2 days agoToday's Research Daily features new research reports on 16 major stocks, including NVIDIA Corporation (NVDA), Tesla, Inc. (TSLA) and Linde plc (LIN), as...
Iridium secures $94 million Space Force contract By Investing.com
Investing.com· 4 days agoIridium secures $94 million Space Force contract
ASCO: Cautious Big Pharmas double down on past wins—steering clear of radioligands and cell therapy
FierceBiotech· 3 days agoThis year’s American Society of Clinical Oncology (ASCO) conference in Chicago marked a return to...
Triplet Notches Survival Win in Heavily Pretreated DLBCL
MedPage Today· 7 days agoBenefit with BV plus lenalidomide-rituximab seen in those who relapsed after CAR-T or transplant
Ads
related to: crispr therapeutics